Published in Circulation on September 27, 2004
Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol (2009) 2.26
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. JACC Cardiovasc Imaging (2008) 2.14
Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat. Am J Physiol Renal Physiol (2007) 1.88
The dynamic vasa vasorum. Cardiovasc Res (2007) 1.53
Imaging and quantitative analysis of atherosclerotic lesions by CARS-based multimodal nonlinear optical microscopy. Arterioscler Thromb Vasc Biol (2009) 1.40
Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. Circ Res (2012) 1.29
The vasa vasorum in diseased and nondiseased arteries. Am J Physiol Heart Circ Physiol (2009) 1.28
Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation (2009) 1.26
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT. Theranostics (2011) 1.25
Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med (2006) 1.18
Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions. Angiogenesis (2010) 1.17
Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J (2011) 1.13
Imaging atherosclerosis and vulnerable plaque. J Nucl Med (2010) 1.10
Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J (2004) 1.10
Distribution of SPARC during neovascularisation of degenerative aortic stenosis. Heart (2006) 1.09
Radionuclide imaging: a molecular key to the atherosclerotic plaque. J Am Coll Cardiol (2008) 1.08
A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res (2009) 1.06
Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia. Basic Res Cardiol (2009) 1.05
The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Eur J Nucl Med Mol Imaging (2013) 1.02
Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging. Methods Enzymol (2012) 1.01
Carotid plaque neovascularization and hemorrhage detected by MR imaging are associated with recent cerebrovascular ischemic events. AJNR Am J Neuroradiol (2011) 0.99
Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. JACC Cardiovasc Imaging (2010) 0.98
Angiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Hypertension (2011) 0.96
Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol (2010) 0.93
Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler Thromb Vasc Biol (2012) 0.93
Diabetes and coronary heart disease: a risk factor for the global epidemic. Int J Hypertens (2012) 0.91
Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling. Circulation (2014) 0.91
Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability. Circ Cardiovasc Imaging (2009) 0.91
The adventitia: the outs and ins of vascular disease. Cardiovasc Res (2007) 0.90
Aortic implantation of mesenchymal stem cells after aneurysm injury in a porcine model. J Surg Res (2011) 0.89
Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J Angiogenes Res (2009) 0.88
Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI. J Magn Reson Imaging (2008) 0.88
Coronary computed tomography and magnetic resonance imaging. Curr Probl Cardiol (2009) 0.88
Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using ¹⁸F-fluoromisonidazole positron emission tomographic imaging. Circ Cardiovasc Imaging (2014) 0.87
Alcohol and cardiovascular disease--modulation of vascular cell function. Nutrients (2012) 0.87
Atherogenesis and iron: from epidemiology to cellular level. Front Pharmacol (2014) 0.87
Quantification of plaque neovascularization using contrast ultrasound: a histologic validation. Eur Heart J (2010) 0.86
Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview. Curr Med Chem (2009) 0.86
Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease. Am J Physiol Heart Circ Physiol (2010) 0.86
Comparison of gadofluorine-M and Gd-DTPA for noninvasive staging of atherosclerotic plaque stability using MRI. Circ Cardiovasc Imaging (2009) 0.86
Magnetic resonance plaque imaging to predict the occurrence of the slow-flow phenomenon in carotid artery stenting procedures. Neuroradiology (2010) 0.85
Red blood cell, hemoglobin and heme in the progression of atherosclerosis. Front Physiol (2014) 0.85
Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.84
Potential therapeutic effects of mTOR inhibition in atherosclerosis. Br J Clin Pharmacol (2015) 0.84
Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury. J Biol Chem (2014) 0.83
CD105 positive neovessels are prevalent in early stage carotid lesions, and correlate with the grade in more advanced carotid and coronary plaques. J Angiogenes Res (2009) 0.83
Cardiovascular magnetic resonance in carotid atherosclerotic disease. J Cardiovasc Magn Reson (2009) 0.83
Multimodality imaging of carotid atherosclerotic plaque: Going beyond stenosis. Indian J Radiol Imaging (2013) 0.83
SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries. J Cardiovasc Magn Reson (2013) 0.82
MR molecular imaging of aortic angiogenesis. JACC Cardiovasc Imaging (2010) 0.82
The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications? Thromb J (2010) 0.82
Atherosclerosis and atheroma plaque rupture: normal anatomy of vasa vasorum and their role associated with atherosclerosis. ScientificWorldJournal (2014) 0.82
Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and α(v)β(3) Integrin. Int J Mol Imaging (2012) 0.81
Relationship between enhanced intensity of contrast enhanced ultrasound and microvessel density of aortic atherosclerostic plaque in rabbit model. PLoS One (2014) 0.81
Atherogenesis may involve the prooxidant and proinflammatory effects of ferryl hemoglobin. Oxid Med Cell Longev (2013) 0.81
Molecular imaging of plaque vulnerability. J Nucl Cardiol (2014) 0.81
Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice. Atherosclerosis (2015) 0.81
Multi-modal CT scanning in the evaluation of cerebrovascular disease patients. Cardiovasc Diagn Ther (2014) 0.80
Atherosclerosis and atheroma plaque rupture: imaging modalities in the visualization of vasa vasorum and atherosclerotic plaques. ScientificWorldJournal (2014) 0.80
Finite element analysis of mechanics of neovessels with intraplaque hemorrhage in carotid atherosclerosis. Biomed Eng Online (2015) 0.80
Assessment of atherosclerotic plaques in the rabbit abdominal aorta with interleukin-8 monoclonal antibody-targeted ultrasound microbubbles. Mol Biol Rep (2013) 0.80
Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages. FASEB J (2009) 0.80
Role of Tie1 in shear stress and atherosclerosis. Trends Cardiovasc Med (2011) 0.79
Hemoglobin as a possible biochemical index of hypertension-induced vascular damage. J Physiol Anthropol (2016) 0.79
Perfluorocarbon nanoparticles: evolution of a multimodality and multifunctional imaging agent. Scientifica (Cairo) (2014) 0.79
Surface expression of CXCR4 on circulating CD133progenitor cells is associated with plaque instability in subjects with carotid artery stenosis. J Angiogenes Res (2009) 0.79
CD40 in coronary artery disease: a matter of macrophages? Basic Res Cardiol (2016) 0.78
Validation of a new animal model of vulnerable plaques by intravascular optical coherence tomography in vivo. J Biomed Biotechnol (2012) 0.78
An assessment of the vulnerability of carotid plaques: a comparative study between intraplaque neovascularization and plaque echogenicity. BMC Med Imaging (2013) 0.78
Advances in nanotechnology for the management of coronary artery disease. Trends Cardiovasc Med (2012) 0.78
Interdependent biological systems, multi-functional molecules: the evolving role of tissue factor pathway inhibitor beyond anti-coagulation. Thromb Res (2010) 0.78
Subacute inflammatory activation in subjects with acute coronary syndrome and left ventricular dysfunction. Inflammation (2012) 0.78
Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque. Circ Cardiovasc Imaging (2016) 0.78
Flk-1/KDR mediates ethanol-stimulated endothelial cell Notch signaling and angiogenic activity. J Vasc Res (2014) 0.77
Cystathionine γ-lyase is expressed in human atherosclerotic plaque microvessels and is involved in micro-angiogenesis. Sci Rep (2016) 0.77
Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition. PLoS One (2015) 0.77
Radial modulation contrast imaging using a 20-MHz single-element intravascular ultrasound catheter. IEEE Trans Ultrason Ferroelectr Freq Control (2014) 0.76
The therapeuatic effect of Endostar on soft carotid plaque neovascularization in patients with non-small cell lung cancer. Sci Rep (2015) 0.76
Vasa vasorum and molecular imaging of atherosclerotic plaques using nonlinear contrast intravascular ultrasound. Neth Heart J (2007) 0.76
Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology. Am J Physiol Heart Circ Physiol (2012) 0.76
Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy. Thromb J (2007) 0.76
Registration of dynamic contrast-enhanced MRI of the common carotid artery using a fixed-frame template-based squared-difference method. J Magn Reson Imaging (2013) 0.76
Nanoimaging in cardiovascular diseases: Current state of the art. Indian J Med Res (2015) 0.76
Thalidomide influences atherogenesis in aortas of ApoE(-/-)/LDLR (-/-) double knockout mice: a nano-CT study. Int J Cardiovasc Imaging (2014) 0.76
Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits. Nanomedicine (2015) 0.76
Paclitaxel-Coated Balloons: Investigation of Drug Transfer in Healthy and Atherosclerotic Arteries - First Experimental Results in Rabbits at Low Inflation Pressure. Cardiovasc Drugs Ther (2016) 0.75
The Role of CC-Chemokines in the Regulation of Angiogenesis. Int J Mol Sci (2016) 0.75
Integrin signaling in atherosclerosis. Cell Mol Life Sci (2017) 0.75
The therapeutic effect of bevacizumab on plaque neovascularization in a rabbit model of atherosclerosis during contrast-enhanced ultrasonography. Sci Rep (2016) 0.75
Platelets as an indicator of vascular repair in elderly Japanese men. Oncotarget (2016) 0.75
Sex-dependent aortic valve pathology in patients with rheumatic heart disease. PLoS One (2017) 0.75
Activation of CD137 Signaling Promotes Angiogenesis in Atherosclerosis via Modulating Endothelial Smad1/5-NFATc1 Pathway. J Am Heart Assoc (2017) 0.75
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA (2005) 5.83
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet (2011) 4.67
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol (2002) 4.48
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med (2007) 3.40
Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation (2012) 3.38
Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol (2005) 3.34
Training cardiovascular fellows in cardiovascular magnetic resonance and vascular imaging; Current status following the core cardiovascular training symposium (COCATS-2) guidelines. J Am Coll Cardiol (2004) 2.67
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation (2007) 2.59
Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging (2009) 2.56
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med (2008) 2.52
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation (2003) 2.52
Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging (2012) 2.50
Neovascularization in human atherosclerosis. Circulation (2006) 2.44
Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology (2010) 2.43
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol (2007) 2.32
OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging (2013) 2.31
Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Arch Intern Med (2003) 2.29
Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol (2005) 2.23
Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol (2009) 2.23
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation (2004) 2.16
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol (2002) 2.14
Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use. Catheter Cardiovasc Interv (2009) 2.09
Insights into degenerative aortic valve disease. J Am Coll Cardiol (2007) 2.09
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol (2010) 2.07
Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation (2002) 2.00
Refractory angina pectoris: mechanism and therapeutic options. J Am Coll Cardiol (2002) 1.98
Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J (2008) 1.96
Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation (2002) 1.94
Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol (2013) 1.93
CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol (2002) 1.92
Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation (2007) 1.91
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 1.87
Intravascular modalities for detection of vulnerable plaque: current status. Arterioscler Thromb Vasc Biol (2003) 1.86
MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med (2006) 1.79
MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol (2002) 1.79
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.79
MRI of carotid atherosclerosis: clinical implications and future directions. Nat Rev Cardiol (2010) 1.78
Systems pharmacology of adverse event mitigation by drug combinations. Sci Transl Med (2013) 1.78
Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov (2011) 1.78
Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol (2008) 1.73
Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol (2012) 1.72
Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov (2004) 1.71
Targeting preschool children to promote cardiovascular health: cluster randomized trial. Am J Med (2012) 1.70
Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells. Circ Res (2012) 1.68
Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J (2004) 1.68
Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation (2008) 1.68
Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol (2005) 1.67
Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression withanti-apoptotic Bcl-2 and HSP47 in arterial repair. J Am Coll Cardiol (2003) 1.67